The research calculated pooled mean differences for various blood parameters (HOMA-IR, FBG (mg/dL), fasting insulin (μU/mL), triglyceride (mg/dL), and CRP (mg/L)) in NAFLD and healthy populations, as well as obese and non-obese groups. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.